Search
for
Sort by
Research 751–780 of 881
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Alopecia areata
- Clinical Presentations and Comorbidities of Pediatric Alopecia Areata
- Correlation of clinical and trichoscopy features with the degree of histologic inflammation in lichen planopilaris and frontal fibrosing alopecia in a cross-sectional study
- Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil
- Cancer-Related Alopecia: From Etiologies to Global Management
- Towards developing an organotypic model for the preclinical study and manipulation of human hair matrix-dermal papilla interactions
- A Novel Atypical Presentation of Frontal Fibrosing Alopecia Involving the Frontoparietal Scalp
- Treatment options for alopecia areata
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Eyebrow Restoration in Deep Facial Burn: Follicular Unit Extraction Hair Transplantation after Nanofat Graft
- Minimally Invasive Removal of Leukotrichia and Hair Transplantation: A 2-Step Surgery in the Treatment of Stable Follicular Vitiligo
- Differentiation of frontal fibrosing alopecia and Lichen planopilaris on trichoscopy: A comprehensive review
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)
- Alopecia areata: medical treatments
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Drug-induced hair pigmentation: Clinical perspectives and updates
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Drug-induced scarring and permanent alopecia
- Alopecia Areata of the Nails: Diagnosis and Management
- Janus kinase inhibitors for alopecia areata: A narrative review
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Transdermal delivery of a new hair growth promoting solution in patients with hair loss
- Dermatologic Adverse Events from Cancer Treatments
- Age-Induced Hair Graying and Oxidative Stress